Comments on the failure of intensive self-regulatory treatment with chronic daily headache.
AI Summary
Key Findings
Abstract
Non-pharmacological therapy of primary headache conditions including chronic daily headache (CDH) is not well-studied. Barton and Blanchard report on their experience with intensive self-regulatory treatment in a cohort of patients with CDH. This negative trial provides preliminary observations that need further investigations in controlled, adequately powered clinical study.
Affiliation
Lilly Research Laboratories, A divisio of Eli Lily & Co., Lilly Corporate Center, Drop Code 1730, Indianapolis, Indiana 46285. [email protected]
External References
- PubMed ID:
- 11802681
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.